Wealth Enhancement Advisory Services LLC Acquires 15,117 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Wealth Enhancement Advisory Services LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 39.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 53,903 shares of the medical instruments supplier's stock after buying an additional 15,117 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in DENTSPLY SIRONA were worth $805,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA during the 4th quarter valued at about $26,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares in the last quarter. True Wealth Design LLC grew its holdings in DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after buying an additional 1,950 shares in the last quarter. Quarry LP grew its holdings in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after buying an additional 780 shares in the last quarter. Finally, Signaturefd LLC grew its holdings in DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after buying an additional 3,706 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

XRAY traded down $0.04 during trading on Friday, hitting $16.54. The company's stock had a trading volume of 1,623,756 shares, compared to its average volume of 2,938,914. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.95. The business's 50 day simple moving average is $15.70 and its 200-day simple moving average is $16.47. The firm has a market cap of $3.30 billion, a PE ratio of -3.64, a P/E/G ratio of 1.19 and a beta of 0.94. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The business had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. DENTSPLY SIRONA's revenue for the quarter was down 7.8% on a year-over-year basis. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, June 27th. This represents a $0.64 annualized dividend and a yield of 3.87%. DENTSPLY SIRONA's payout ratio is -14.10%.

Analysts Set New Price Targets

XRAY has been the subject of several recent analyst reports. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a report on Tuesday, April 15th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Saturday. Piper Sandler lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. UBS Group reduced their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Finally, Barrington Research increased their target price on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of "Hold" and an average target price of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.